semaglutide for weight loss

Semaglutide for Weight Loss: How It Works and How It Stacks Up Against Other Medications

by Precious

August 15, 2025 06:00 am ET Estimated Read Time: 4 Minutes

What Is Semaglutide?

Semaglutide is a GLP‑1 receptor agonist originally approved for type 2 diabetes (Ozempic, Rybelsus). The 2.4 mg injectable version, branded Wegovy, is FDA‑approved specifically for chronic weight management in adults with obesity or overweight and related health issues.

Mechanism of Action:

  • Suppresses appetite by signaling fullness to the brain

  • Slows gastric emptying, which prolongs satiety

  • Enhances insulin secretion and suppresses glucagon, aiding metabolic balance

Proven Effectiveness: How Much Weight Can You Lose?

Clinical trials (STEP program) show about 15% average body weight loss over 68 weeks with Wegovy, compared to ~2–3% with lifestyle changes alone. Real-world studies confirm strong weight loss—but highlight the importance of adherence to dose and lifestyle for optimal results.

Semaglutide vs. Other Weight-Loss Medications

1. Tirzepatide (Mounjaro/Zepbound)

  • Dual action (GLP‑1 + GIP) leads to more potent weight reduction

  • Trials show up to 20–22% weight loss vs. ~14–15% with semaglutide

  • Meta-analyses confirm superior weight outcomes

  • Side effects (nausea, GI discomfort) and higher cost are considerations

2. Liraglutide (Saxenda)

  • GLP‑1 agonist: ~4–6% bodyweight loss

  • Requires daily injections; less effective compared to once-weekly semaglutide

3. Orlistat (Xenical)

  • Works by blocking fat absorption in the gut

  • Yield ~3 kg weight loss; common side effect: oily stools 

4. Phentermine/topiramate (Qsymia)

  • Sympathomimetic appetite suppressant + topiramate combination

  • ~10% weight loss; approved for short-term use (phentermine) to chronic (Qsymia)

Quick Comparison Overview:

Medication

Mechanism

Avg Weight Loss

Injection Frequency

Semaglutide (Wegovy)

GLP‑1 agonist

~15%

Once weekly

Tirzepatide

GLP‑1 + GIP agonist

~20–22%

Once weekly

Liraglutide

GLP‑1 agonist

~4–6%

Daily

Orlistat

GI fat absorption

~3 kg (~3%)

3x daily (with meals)

Phentermine/topiramate

Appetite suppressant

~10%

Qsymia daily/phentermine short

 

Side Effects & Safety

All medications share common side effects like nausea, constipation, diarrhea, and abdominal discomfort. Semaglutide poses a low risk of pancreatitis; the boxed warning includes potential thyroid C-cell tumors in rodents. Real-world data reports muscle mass loss on semaglutide, especially without proper protein intake and resistance training.

Important Considerations:

  • Discontinuation risks: many regain 50–60% of lost weight if meds stop

  • Eating disorders: GLP‑1s may exacerbate disordered eating and should be used cautiously

  • Cardiovascular & brain health: early research suggests GLP‑1s may lower stroke, dementia, and mortality risk

Why Choose Semaglutide?

  • Powerful weight loss (~15%) with once-weekly convenience

  • FDA-approved for chronic weight management

  • Strong research backing (STEP trials)

  • Numerous

Choosing the Right Medication for You

Who may favor semaglutide?

  • People seeking significant, sustained weight loss

  • Preference for less frequent dosing

  • Good tolerance to GLP‑1 side effects

  • Access via prescription and insurance or out-of-pocket

When tirzepatide might be better:

  • People targeting maximum weight loss (>20%)

  • Tolerant of GI effects and higher cost

Alternative options:

  • Liraglutide: daily shots, less weight loss

  • Orlistat: inexpensive, but GI-focused

  • Phentermine/Qsymia: short-term appetite suppression

Getting Started with Dosepop

At Dosepop, we’re committed to helping you find the ideal path:

  1. Comprehensive evaluation: medical history, weight-loss goals, comorbidities

  2. Medication guidance: based on safety, effectiveness, and lifestyle fit

  3. Prescriptions and follow-up: virtual consults and monitoring

  4. Support plan: diet and exercise resources to maximize results and maintain lean mass

Dosepop leverages a holistic, evidence-based model to support not just weight loss—but healthy, sustainable wellness.

Semaglutide Frequently Asked Questions

Is semaglutide better than Ozempic for weight loss?
Ozempic and Wegovy both contain semaglutide—the difference is dose. Wegovy (2.4 mg) is FDA-approved for obesity; Ozempic (0.5–1 mg) is for diabetes—but off-label use for weight loss is common 

How long does semaglutide take to work?
Users often start noticing appetite suppression within weeks; full weight loss benefits appear after months of consistent therapy. STEP trials spanned ~68 weeks.

What is the cost of semaglutide for weight loss?
Typically between $5,000–$10,000/year before insurance. Dosepop discusses coverage, discounts, and out-of-pocket buy-in.

Can you take semaglutide and still build muscle?
Yes—by incorporating adequate protein (1.2–1.6 g/kg) and resistance training, users can preserve lean mass and avoid estimated muscle loss reported in trials.

Final Take

Semaglutide is a clinically validated, high-efficacy weight loss medication with the convenience of once-weekly dosing. When compared with alternatives, it offers strong results, though newer options like tirzepatide may deliver even more dramatic outcomes for some.

At Dosepop, we help you find the best, safest path—whether that’s semaglutide, tirzepatide, or another therapy—while ensuring you have the support to maintain your results long-term.

Ready to Begin?

If you’re looking for semaglutide for weight loss, how semaglutide works, or semaglutide cost, start with Dosepop’s expert team. Visit Dosepop Weight Loss to schedule a consultation, get personalized medical advice, and begin your transformation journey today.

 

img

No gatekeeping, just skincare!

Simplify your skincare routine with science-backed, effective products recommended by the Dosepop medical team.

img img